Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions

NCT05464472 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-07-19

No results posted yet for this study

Summary

Interventional implantation of the aortic valve (Transcatheter Aortic Valve Implantation; TAVI) may alter neurocognitive functions. We aim to differentiate the changes in cognitive functions after a TAVI.

Conditions

  • Cognition Disorder

Interventions

DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

Guideline/ FDA approved implantation of a Transcatheter Aortic Valve Implantation (TAVI)

Sponsors & Collaborators

  • Helios University Hospital Wuppertal

    lead OTHER

Principal Investigators

  • Marc Vorpahl, Prof. Dr. · Helios Wuppertal

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-31
Primary Completion
2022-12-31
Completion
2023-12-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05464472 on ClinicalTrials.gov